Show simple item record

dc.contributor.authorPennap, Dinci
dc.contributor.authorBurcu, Mehmet
dc.contributor.authorZito, Julie Magno
dc.date.accessioned2015-11-09T15:02:51Z
dc.date.available2015-11-09T15:02:51Z
dc.date.issued2013-09
dc.identifier.urihttp://hdl.handle.net/10713/4878
dc.descriptionAt head of title: Maryland Center for Excellence in Regulatory Science & Innovation. Authors' affiliation is University of Maryland School of Pharmacy, Pharmaceutical Health Services Research Department.en_US
dc.language.isoen_USen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectFDAen_US
dc.subject.lcshRaceen_US
dc.subject.lcshEthnicityen_US
dc.subject.lcshUnited States. Food and Drug Administrationen_US
dc.subject.meshAntipsychotic Agentsen_US
dc.subject.meshContinental Population Groupsen_US
dc.subject.meshChilden_US
dc.subject.meshAdolescenten_US
dc.titleRacial/Ethnic Differences in Pediatric Antipsychotic Use by FDA Labeled/Off-label Statusen_US
dc.typePoster/Presentationen_US
dc.identifier.ispublishedNoen_US
dc.description.urinameFull Texten_US
refterms.dateFOA2019-02-19T18:05:18Z


Files in this item

Thumbnail
Name:
MCERSI 2013.pptx
Size:
1.136Mb
Format:
Microsoft PowerPoint 2007
Description:
FDA MCERSI Poster

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/